Transcarent Acquires Accolade for $621 Million to Enhance Healthcare Access

San Francisco, Thursday, 9 January 2025.
Transcarent announced its acquisition of Accolade for $621 million on January 8, 2025, integrating AI-driven solutions to improve healthcare quality and affordability, with completion expected by mid-2025.